66 unknown. 66 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 66 | Unknown 66 |
Follow Mental Disorders: new trials by email Literature Review of Mental Disorders trials Research Report on Mental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study Inhaled Melatonin (100 μg), Oral Melatonin (4 mg) - Insomnia | Early Phase 1 | Unknown | Woolcock Institute of Medical Research | 5 | 2025-07-01 | 2025-07-18 |
| Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety Measure concentrations of CBD in spot urine collections from subjects treated with inhaled CBD, Determine the presence and concentration of CBD in subject's plasma with inhaled CBD - Generalized Anxiety Disorder | Early Phase 1 | Unknown | Trinity Hypertension & Metabolic Research Institute | 40 | 2024-12-01 | 2024-10-24 |
| Efficacy of Dexmedetomidine vs Midazolam for Early Extubation in Critically Ill Agitated Patients Undergoing Weaning Dexmedetomidine Hydrochloride - Agitation, Emergence | Early Phase 1 | Unknown | Sheikh Zayed Medical College | 66 | 2024-11-01 | 2024-08-07 |
| Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues Decompartmentalization Framework, Liquid Herbal TInctures, Mental Imagery - Schizoaffective Disorder, Bipolar Type, Bipolar Disorder | Early Phase 1 | Unknown | The Essence of Integrative Health and Medicine Practice | 30 | 2024-10-10 | 2024-08-12 |
| Quetiapine Versus Trazadone in Women With Postpartum Depression Trazodone, Quetiapine - Postpartum Depression | Early Phase 1 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 50 | 2024-09-01 | 2024-08-09 |
| Losartan and Emotional Learning Losartan potassium 50mg, Placebo - Emotional Processing | Early Phase 1 | Unknown | University of Oxford | 60 | 2024-08-14 | 2024-10-04 |
| Digital Support Intervention for Pregnant People with Opioid Use Disorders Digital technology, Bibliotherapy - Digital Intervention, Bibliotherapy | Early Phase 1 | Unknown | University of South Carolina | 32 | 2024-06-04 | 2025-02-17 |
| Cannabidiol Effects on Fear Extinction in Social Phobia Fear extinction, Cannabidiol Cap/Tab, Placebo - Social Anxiety Disorder | Early Phase 1 | Unknown | Hartford Hospital | 20 | 2024-04-30 | 2024-04-19 |
| Losartan and Emotional Processing in Young People Losartan potassium, Placebo - Emotional Processing | Early Phase 1 | Unknown | University of Oxford | 60 | 2024-03-07 | 2025-06-15 |
| Pain After Removal of Mandibular Third Molars With or Without Advanced Platelet-rich Fibrin Advanced platelet-rich fibrin in the ekstraction socket - Pain Syndrome | Early Phase 1 | Unknown | Aalborg University Hospital | 80 | 2024-01-10 | 2024-04-22 |
| Emergency Delirium in Pediatrics Undergoing Tonsillectomy and Adenoidectomy Dexmedetomidine and Midazolam - Emergence Delirium | Early Phase 1 | Unknown | Esraa Abdel Azez Soltan Mohamed Zayed | 100 | 2024-01-01 | 2024-01-22 |
| Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI) Plasma exchenge - Alzheimer Disease | Early Phase 1 | Unknown | Oslo University Hospital | 10 | 2023-12-07 | 2024-01-31 |
| Nicotine and Pavlovian Bias Nicotine, Placebo - Nicotine Vaping, Nicotine Dependence | Early Phase 1 | Unknown | University of Southern California | 40 | 2023-10-25 | 2023-11-09 |
| A Supplement on Cognitive Function and Brain Activity in Middle Age and Older Healthy Adults PoZibio, Placebo - Cognitive Decline | Early Phase 1 | Unknown | Aberystwyth University | 40 | 2023-06-15 | 2023-06-07 |
| Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study Lithium - Depressive Disorder | Early Phase 1 | Unknown | Melbourne Health | 20 | 2023-06-01 | 2023-08-01 |
| Effect of Cannabidiol (CBD) on Vision and Driving Placebo (CBD 0%), CBD 15%, CBD 30% - Cannabis Use | Early Phase 1 | Unknown | Universidad de Granada | 60 | 2023-02-01 | 2024-03-22 |
| The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia Riluzole - Treatment-resistant Schizophrenia, Treatment-responsive Schizophrenia | Early Phase 1 | Unknown | King's College London | 288 | 2022-11-14 | 2024-03-05 |
| A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression Volatile Oil of Cang-Ai, Bergamot essential oils - Depressive Disorder, Mental Disorder in Adolescence | Early Phase 1 | Unknown | Jieqiong Cui | 60 | 2022-11-01 | 2022-10-20 |
| Ketamine Therapy Experiential Education Study Ketamine hydrochloride injection - Psychedelic Experiences, Therapeutic Alliance | Early Phase 1 | Unknown | Integrative Psychiatry Institute | 500 | 2022-09-01 | 2022-07-21 |
| Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response Tadalafil 5mg/sildenafil 25 mg - Erectile Dysfunction and Neutrophil Lymphocyte Ratio | Early Phase 1 | Unknown | Assiut University | 74 | 2022-08-01 | 2022-07-20 |
Showing 20 of 66. Sign in to see all of them.
Anxiety Disorders (7) · Depressive Disorder (5) · Depression (4) · Depressive Disorder, Major (4) · Emergence Delirium (4) · Schizophrenia (4) · Attention Deficit Disorder with Hyperactivity (3) · Autistic Disorder (3) · Opioid-Related Disorders (3) · Psychotic Disorders (3) · Sleep Initiation and Maintenance Disorders (3) · Stress Disorders, Post-Traumatic (3) · Alcoholism (2) · Alzheimer Disease (2) · Anorexia Nervosa (2)
Nervous System Diseases (16) · Pathological Conditions, Signs and Symptoms (15) · Signs and Symptoms (13) · Mood Disorders (12) · Neurocognitive Disorders (12) · Behavior (11) · Chemically-Induced Disorders (10) · Neurologic Manifestations (10) · Neurodevelopmental Disorders (8) · Pathologic Processes (8) · Substance-Related Disorders (8) · Schizophrenia Spectrum and Other Psychotic Disorders (7) · Behavioral Symptoms (6) · Depressive Disorder (6)
Deep Brain Stimulation (4) · Dexmedetomidine (4) · Cannabidiol (2) · Cognitive Behavioral Therapy (2) · Escitalopram (2) · Ketamine (2) · Losartan (2) · Midazolam (2) · Mindfulness (2) · Nicotine (2) · Propofol (2) · Sodium Chloride (2) · Therapeutics (2) · (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (1) · Acetaminophen (1)
Beijing Pins Medical Co., Ltd (5) · Assiut University (2) · King's College London (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · University of Oxford (2) · Aalborg University Hospital (1) · Aberystwyth University (1) · Alen Greš (1) · Ayelet Omer Armon (1) · Boston VA Research Institute, Inc. (1) · Brooke Army Medical Center (1) · Cairo University (1) · Charles University, Czech Republic (1) · Children's Hospital Los Angeles (1) · China Academy of Chinese Medical Sciences (1)
China (11) · United States (11) · United Kingdom (8) · Australia (3) · Egypt (3) · Israel (3) · Canada (2) · Brazil (1) · Croatia (1) · Czechia (1) · Denmark (1) · Germany (1) · Norway (1) · Singapore (1) · Spain (1)
Li Luming, PhD (5) · Andrea Reinecke, PhD (2) · A Elias (1) · Amanda J Lloyd, PhD, BSc (1) · Chelsey R Wilks, PhD (1) · Chunshui Yu, MD (1) · Congze Wang (1) · David Nutt, MD, PhD (1) · David Tolin, Ph.D. (1) · David Veale, MRCPsych (1) · Esther Adi-Japha, PhD (1) · Faith A Richardson, BSW, MPA, PhD (1) · Feng Wang (1)
PMID 25885697, PMID 26619358, PMID 27869829, PMID 27918562, PMID 28521048, PMID 28789647, PMID 29632383, PMID 32064663, PMID 32373032, PMID 34784941, PMID 37225710, PMID 38265467, PMID 38701878, PMID 40224600, PMID 41438154, PMID 42028138, PMID 42489967